Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Food on NNC0385-0434 Pharmacokinetics
NCT05091073Phase 1Completed
- Sponsor
- Novo Nordisk
- Start
- Dec 2021
- Primary completion
- Apr 2022
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of NNC0385-0434 in hypercholesterolemia (3 arms), sponsored by Novo Nordisk. Primary endpoint: Area under the plasma concentration-time curve from 0 to 24 h after last dose. Started Dec 2021; status: completed.
02
Drugs
NNC0385-0434
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT05091073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05091073.